1. Home
  2. VINP vs CMPS Comparison

VINP vs CMPS Comparison

Compare VINP & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vinci Partners Investments Ltd.

VINP

Vinci Partners Investments Ltd.

HOLD

Current Price

$10.25

Market Cap

702.6M

Sector

Finance

ML Signal

HOLD

Logo COMPASS Pathways Plc American Depository Shares

CMPS

COMPASS Pathways Plc American Depository Shares

HOLD

Current Price

$6.37

Market Cap

778.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VINP
CMPS
Founded
2009
2020
Country
Brazil
United Kingdom
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
702.6M
778.7M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
VINP
CMPS
Price
$10.25
$6.37
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
8
Target Price
$14.00
$27.14
AVG Volume (30 Days)
73.2K
4.5M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
1.16%
N/A
EPS Growth
N/A
0.86
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$23.80
N/A
Revenue Next Year
$13.97
N/A
P/E Ratio
$24.41
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.66
$2.25
52 Week High
$13.61
$8.90

Technical Indicators

Market Signals
Indicator
VINP
CMPS
Relative Strength Index (RSI) 23.09 43.07
Support Level $9.25 $5.95
Resistance Level $10.87 $7.02
Average True Range (ATR) 0.60 0.50
MACD -0.18 -0.09
Stochastic Oscillator 0.19 3.93

Price Performance

Historical Comparison
VINP
CMPS

About VINP Vinci Partners Investments Ltd.

Vinci Compass Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Equity, Equities, Real Assets, Credit, Global IP&S, and Corporate Advisory. The company's majority of its revenue comes from the Private Equity segment, which is comprised of five business lines: private equity, real estate, infrastructure, credit, and special situations.

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

Share on Social Networks: